Bermejo B - Search Results

1

Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.

Ferrer J, Villarino MA, Encabo G, Felip E, Bermejo B, Vilà S, Orriols R. Ferrer J, et al. Among authors: bermejo b. Cancer. 1999 Oct 15;86(8):1488-95. doi: 10.1002/(sici)1097-0142(19991015)86:8<1488::aid-cncr15>3.0.co;2-y. Cancer. 1999. PMID: 10526277

2

Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy.

Felip E, Del Campo JM, Rubio D, Vidal MT, Colomer R, Bermejo B. Felip E, et al. Among authors: bermejo b. Cancer. 1995 Apr 15;75(8):2147-52. doi: 10.1002/1097-0142(19950415)75:8<2147::aid-cncr2820750818>3.0.co;2-8. Cancer. 1995. PMID: 7697606

3

Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.

Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V. Del Campo JM, et al. Among authors: bermejo b. Gynecol Oncol. 1994 Apr;53(1):27-32. doi: 10.1006/gyno.1994.1082. Gynecol Oncol. 1994. PMID: 8175018 Clinical Trial.

4

Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Solé LA, Baselga J. Bellmunt J, et al. Among authors: bermejo b. Cancer. 1997 Nov 15;80(10):1966-72. doi: 10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>3.0.co;2-w. Cancer. 1997. PMID: 9366300 Clinical Trial.

5

Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories.

Blancas I, Gómez FJ, Bermejo B, Hennessy BT, Chirivella I, Magro A, Caballero A, Ferrer J, Valero V, Lluch A. Blancas I, et al. Among authors: bermejo b. Clin Breast Cancer. 2009 Nov;9(4):231-6. doi: 10.3816/CBC.2009.n.039. Clin Breast Cancer. 2009. PMID: 19933078

6

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

Pérez-Fidalgo JA, Eroles P, Ferrer J, Bosch A, Burgués O, Martínez F, Bermejo B, Lluch A, González-Angulo AM. Pérez-Fidalgo JA, et al. Among authors: bermejo b. Breast. 2013 Oct;22(5):974-9. doi: 10.1016/j.breast.2013.05.014. Epub 2013 Jun 25. Breast. 2013. PMID: 23809906

7

¹⁸F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

Quintela-Fandino M, Lluch A, Manso L, Calvo I, Cortes J, García-Saenz JA, Gil-Gil M, Martinez-Jánez N, Gonzalez-Martin A, Adrover E, de Andres R, Viñas G, Llombart-Cussac A, Alba E, Guerra J, Bermejo B, Zamora E, Moreno-Anton F, Pernas Simon S, Carrato A, Lopez-Alonso A, Escudero MJ, Campo R, Carrasco E, Palacios J, Mulero F, Colomer R. Quintela-Fandino M, et al. Among authors: bermejo b. Clin Cancer Res. 2017 Mar 15;23(6):1432-1441. doi: 10.1158/1078-0432.CCR-16-0738. Epub 2016 Sep 1. Clin Cancer Res. 2017. PMID: 27587436 Free article. Clinical Trial.

8

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer.

Pérez-Núñez I, Rozalén C, Palomeque JÁ, Sangrador I, Dalmau M, Comerma L, Hernández-Prat A, Casadevall D, Menendez S, Liu DD, Shen M, Berenguer J, Ruiz IR, Peña R, Montañés JC, Albà MM, Bonnin S, Ponomarenko J, Gomis RR, Cejalvo JM, Servitja S, Marzese DM, Morey L, Voorwerk L, Arribas J, Bermejo B, Kok M, Pusztai L, Kang Y, Albanell J, Celià-Terrassa T. Pérez-Núñez I, et al. Among authors: bermejo b. Nat Cancer. 2022 Mar;3(3):355-370. doi: 10.1038/s43018-022-00339-4. Epub 2022 Mar 17. Nat Cancer. 2022. PMID: 35301507

9

[The prognostic value of eicosanoids in the acute respiratory distress syndrome].

Masclans JR, Bermejo B, Picó M, de Latorre FJ, Rodríguez-Roisin R, Planas M. Masclans JR, et al. Among authors: bermejo b. Med Clin (Barc). 1999 Jan 30;112(3):81-4. Med Clin (Barc). 1999. PMID: 10074613 Spanish.

10

Amniotic fluid glucose and cytokines values in the early diagnosis of amniotic infection in patients with preterm labor and intact membranes.

González-Bosquet E, Cerqueira MJ, Dominguez C, Gasser I, Bermejo B, Cabero L. González-Bosquet E, et al. Among authors: bermejo b. J Matern Fetal Med. 1999 Jul-Aug;8(4):155-8. doi: 10.1002/(SICI)1520-6661(199907/08)8:4<155::AID-MFM3>3.0.CO;2-2. J Matern Fetal Med. 1999. PMID: 10406297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters